Stockreport

A Look At Cogent Biosciences (COGT) Valuation After FDA NDA Acceptance And Shifting Institutional Positions [Yahoo! Finance]

Cogent Biosciences, Inc.  (COGT) 
Last cogent biosciences, inc. earnings: 11/8 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.cogint.com/investor-relations
PDF The key catalyst for Cogent Biosciences (COGT) is the FDA's acceptance of its New Drug Application for bezuclastinib in NonAdvanced Systemic Mastocytosis, with a PDUFA [Read more]